One
Prof. Dr. Michael Gütschow

Universität Bonn
Pharmazeutisches Institut
Pharmazeutische & Medizinische Chemie
An der Immenburg 4
D-53121 Bonn
Deutschland

Tel: +49 228 732317
Fax: +49 228 732567

[Email protection active, please enable JavaScript.]

 
Two
Sie sind hier: Startseite AK Gütschow Forschung

Forschung

  • Discovery of Covid-19 therapeutics

    SARS

    Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors (Breidenbach, J., Lemke, C. et al. Angew. Chem. Int. Ed. 2021, 60, 10423-10429).

     SARS_ChemMedChem

    Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 Activity (Schulte, B. et al. ChemMedChem 2022, 17, e202100732).

  • Development of PROTACs
  • Development of PROTACs

    Homo-PROTACs for the Chemical Knockdown of Cereblon (Steinebach, C., Lindner, S. et al. ACS Chem. Biol. 201813, 2771-2782).

     

  • Development of low-molecular inhibitors of human cysteine and serine proteases

    obc_big

A gorge-spanning, high-affinity cholinesterase inhibitor to explore β-amyloid plaques (Elsinghorst, P.W. et al. Org. Biomol. Chem. 2009, 7, 3940-3946).


brunsvicamide b

Model of the cyanobacterial cyclic peptide brunsvicamide B bound to the active site of human leukocyte elastase (Sisay, M.T. et al. ChemMedChem 2009, 4, 1425-1429).


 Reik_Chem_Med_Chem_2
 

Synthesis and radiopharmacological characterization of a fluorine-18-labelled azadipeptide nitrile as PET-tracer for cathepsin imaging in vivo (Löser, R. et al. ChemMedChem 2013, 8, 1330-1344).   

 

 

Janus Inhibitors 3

A bisbenzamidine phosphonate as a Janus-faced inhibitor for trypsin-like serine proteases (Häußler, D. et al. ChemMedChem 2015, 10, 1641-1646).

     

  • Characterization of the key role of the membrane-bound type II transmembrane serine protease matriptase-2 in iron homeostasis

    MTP2 

By cleaving hemojuveline (m-HJV), the bone morphogenetic protein (BMP) co-receptor, matriptase-2 downregulates SMAD signaling leading to suppressed hepcidin expression and increased iron plasma levels (for a review, see: Stirnberg, M. and Gütschow, M. Curr. Pharm. Des. 2013, 19, 1052-1061).

 

Coverpicture_2016_Häußler

Phosphono Bisbenzguanidines as Irreversible Dipeptidomimetic Inhibitors and Activity-Based Probes of Matriptase-2 (Häußler, D. et al. Chem. Eur. J. 2016).

 

 

Characterization of low-molecular weight ligands using active-site-mutated variants of matriptase-2 (Maurer, E. et al. ChemMedChem 2012).

 

 

  • Mechanism of the enzyme-inhibitor interactions, enzyme kinetics, e.g. analysis of the reactions of enzymes with mechanism-based inhibitors and artificial substrates

 

cease1cease2 

Kinetics of the cholesterol esterase-catalyzed hydrolysis of 6,7-dihydro-2-dimethylamino-4H,5H-cyclopenta[4,5]thieno[2,3-d][1,3]oxazin-4-one. Left: Depletion of the compound is illustrated by monitoring UV/VIS-spectra at 10 min-intervals. Right: Hydrolysis of the compound was followed at 350 nm (Pietsch, M. and Gütschow, M. J. Med. Chem. 2005, 48, 8270-8288).

 

 

  • Development of synthetic inhibitors of angiogenesis and TNF-alpha production

    

  • Activity-based probes for proteases

    activity based probes

    An activity-based probe to chemically introduce the green fluorescence for the ex vivo imaging of human cysteine cathepsins (Frizler, M. et al. Org. Biomol. Chem. 2013, 11, 5913-5921).


    Cat_K_Sonde

    An activity-based probe for cathepsin K imaging with excellent potency and selectivity (Lemke, C. et al. J. Med. Chem. 2021, 64, 13793-13806).

  • Synthesis and structural elucidation of bioactive heterocycles, investigations on heterocyclizations, ring cleavages, trapping reactions

 
Synthesis_2009_neu

Investigations on alternative ring closures and analysis of rotational barriers (Häcker, H. G. et al. Synthesis 2009, 1195-1203).


 pao

An access to biologically active aza-Freidinger lactams and E-locked analogs (Ottersbach, P. A. et al. Org. Lett. 2013, 15, 448-451). 

 

 

 sulfonylation_new

Regioselective sulfonylation and intramolecular N- to O-sulfonyl migration as verified by kinetic and crossover experiments (Mertens, M. D. et al. J. Org. Chem. 2013, 78, 8966-8979. 

 

  • Aminobarbituric acid-hydantoin rearrangements


    hydantoins 

    Formation of trisubstituted hydantoins (Meusel, M. et al. J. Org. Chem. 2003, 68, 4684-4692).
     

  • Structure-activity relationships of biologically active heterocycles


cathepsin 

Docking of 2-(4-methylpiperazinyl)-4H-3,1-benzoxazin-4-one toward the active site of cathepsin G (Gütschow, M. et al. Arch. Biochem. Biophys. 2002, 402, 180-191).


Structure-Based_Design_Trypsin-Like_Protease_Inhibitors_2015

Limiting the Number of Potential Binding Modes by Introducing Symmetry into Ligands: Structure-Based Design of Inhibitors for Trypsin-Like Serine Proteases (Furtmann, N. et al. Chem. Eur. J. 2016, 22, 610-625).

Artikelaktionen